reduce basal insulin dose when starting glp-1 receptor agonist GLP1-RA and SGLT2-i: Implementation and Deescalation Strategies | Cardiovascular Drugs and Therapy Beyond GLP-1 Agonists: An Adaptive

This concern may have originated from a 1959 study that first raised the possibility of diuretics affecting glucose metabolism (Freis and Finnerty, 1959) based on the effects of hydrochlorothiazide

The Zepbound prescribing information reports similar findings

IM administration provides faster absorption

It is shown to fortify the gut lining while rapidly healing and protecting against lesions, also reducing inflammation and influencing global health by acting on the gut-brain axis

Retatrutide expands that framework by adding glucagon receptor activity, allowing scientists to explore additional pathways and interactions

There are modest improvements in glucose control but perhaps increased rates of hypoglycaemia